SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008528
Filing Date
2022-05-12
Accepted
2022-05-12 16:03:11
Documents
56
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cycc-20220331x10q.htm   iXBRL 10-Q 960457
2 EX-31.1 cycc-20220331xex31d1.htm EX-31.1 14686
3 EX-31.2 cycc-20220331xex31d2.htm EX-31.2 15228
4 EX-32.1 cycc-20220331xex32d1.htm EX-32.1 5089
5 EX-32.2 cycc-20220331xex32d2.htm EX-32.2 5433
  Complete submission text file 0001558370-22-008528.txt   4469979

Data Files

Seq Description Document Type Size
6 EX-101.SCH cycc-20220331.xsd EX-101.SCH 35541
7 EX-101.CAL cycc-20220331_cal.xml EX-101.CAL 33352
8 EX-101.DEF cycc-20220331_def.xml EX-101.DEF 178245
9 EX-101.LAB cycc-20220331_lab.xml EX-101.LAB 299737
10 EX-101.PRE cycc-20220331_pre.xml EX-101.PRE 264068
50 EXTRACTED XBRL INSTANCE DOCUMENT cycc-20220331x10q_htm.xml XML 618210
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 22917683
SIC: 2834 Pharmaceutical Preparations